Clinical Trial

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-02-27; most recent amendment 2026-02-11.
Status change: Recruiting → Active, Not Recruiting 2026-02-11
Trial Details
NCT Number NCT06284265
Lead Sponsor Materia Medica Holding
Conditions Cystitis Chronic, Cystitis Bacterial, Recurrence of Chronic Bacterial Cystitis
Enrollment 415 participants
Start Date 2023-10-16
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13